Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System

被引:14
|
作者
Alva, Shridhara [1 ]
Brazg, Ronald [2 ]
Castorino, Kristin [3 ]
Kipnes, Mark [4 ]
Liljenquist, David R. [5 ]
Liu, Hanqing [1 ]
机构
[1] Abbott Diabet Care, Alameda, CA 94502 USA
[2] Rainier Clin Res Ctr, Renton, WA USA
[3] Sansum Diabet Res Inst, Santa Barbara, CA USA
[4] Diabet & Glandular Dis Clin, San Antonio, TX USA
[5] Rocky Mt Diabet Ctr, Idaho Falls, ID USA
关键词
FSL3 CGM system; FSL2 CGM system; Continuous glucose monitoring; Self-monitoring blood glucose; YSI reference;
D O I
10.1007/s13300-023-01385-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionWe have evaluated the performance of the FreeStyle Libre (R) 3 continuous glucose monitoring system (FSL3) compared to (1) the venous plasma reference for participants aged >= 6 years and (2) the fingerstick capillary blood glucose (BG) reference for pediatric participants aged 4 and 5 years. The analytical performance of the third-generation factory-calibrated FSL3 CGM system was compared to the plasma venous blood glucose reference using the YSI 2300 STAT PLUS Glucose and Lactate Analyzer (the YSI reference) and the self-monitoring blood glucose (SMBG) reference for participants aged >= 6 years and participants aged 4 and 5 years, respectively.MethodsA total of 108 participants aged >= 4 years with type 1 or type 2 diabetes from four sites in the USA were enrolled in the study. The data of 100 participants were ultimately evaluated. Adult participants (aged >= 18 years) participated in three in-clinic sessions, and pediatric participants (aged 4-17 years) participated in up to two in-clinic sessions, all stratified to provide data for days 1, 2, 3, 7, 8, 9, 12, 13 or 14 of sensor wear. Performance evaluation included accuracy measures, such as proportion of CGM values that fell within +/- 20% or +/- 20 mg/dL (1.1 mmol/L) of the reference glucose values, and difference measures, such as the mean absolute relative difference (MARD) between the CGM and reference values.ResultsData from the 100 study participants were analyzed. The overall MARD was 7.8%, and 93.4% of the CGM values were within +/- 20% or +/- 20 mg/dL of the YSI reference for participants aged >= 6 years, with 6845 CGM-YSI matched pairs. The performance was stable over the 14-day wear period. For participants aged 4-5 years, MARD was 10.0%, and 88.9% of the CGM values were within 20%/20 mg/dL compared to a SMBG reference. No serious adverse events were reported.ConclusionsThe FSL3 CGM system demonstrated accurate performance across the dynamic glycemic range during the 14-day sensor wear period.
引用
收藏
页码:767 / 776
页数:10
相关论文
共 50 条
  • [1] Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System
    Shridhara Alva
    Ronald Brazg
    Kristin Castorino
    Mark Kipnes
    David R. Liljenquist
    Hanqing Liu
    Diabetes Therapy, 2023, 14 : 767 - 776
  • [2] Accuracy of a 14-Day Factory-Calibrated Continuous Glucose Monitoring System With Advanced Algorithm in Pediatric and Adult Population With Diabetes
    Alva, Shridhara
    Bailey, Timothy
    Brazg, Ronald
    Budiman, Erwin S.
    Castorino, Kristin
    Christiansen, Mark P.
    Forlenza, Gregory
    Kipnes, Mark
    Liljenquist, David R.
    Liu, Hanqing
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2022, 16 (01): : 70 - 77
  • [3] Analysis of "Accuracy of a 14-Day Factory Calibrated Continuous Glucose Monitoring System With Advanced Algorithm in Pediatric and Adult Population With Diabetes"
    Kompala, Tejaswi
    Neinstein, Aaron B.
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2022, 16 (01): : 78 - 80
  • [4] Flash Continuous Glucose Monitoring (FreeStyle Libre 14-Day System) for Self-Management of Diabetes Mellitus
    Choi, Hiu Ying Joanna
    AMERICAN FAMILY PHYSICIAN, 2021, 103 (11) : 688 - 690
  • [5] Improved Accuracy of 14-Day Factory-Calibrated FreeStyle Libre System with New Glucose Algorithm
    Karinka, Shridhara Alva
    Bailey, Timothy S.
    Brazg, Ronald L.
    Budiman, Erwin S.
    Castorino, Kristin
    Christiansen, Mark P.
    Liljenquist, David R.
    Liu, Hanqing
    DIABETES, 2019, 68
  • [6] Limitations of 14-Day Continuous Glucose Monitoring Sampling for Assessment of Hypoglycemia and Glycemic Variability in Type 1 Diabetes
    Akturk, Halis Kaan
    DIABETES TECHNOLOGY & THERAPEUTICS, 2024, 26 (07) : 503 - 508
  • [7] Glycemic Variability Assessment with a 14-Day Continuous Glucose Monitoring System: When and How Long to Measure MAGE (Mean Amplitude of Glucose Excursion) for Optimal Reliability?
    Verges, Bruno
    Pignol, Elise
    Rouland, Alexia
    Bouillet, Benjamin
    Baillot-Rudoni, Sabine
    Quilot, Emilienne
    Djeffal, Abdelmadjid
    Petit, Jean Michel
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2022, 16 (04): : 982 - 987
  • [8] Accuracy and Safety of the 15-Day CareSens Air Continuous Glucose Monitoring System
    Kim, Kyung-Soo
    Lee, Seung-Hwan
    Yoo, Won Sang
    Park, Cheol-Young
    DIABETES TECHNOLOGY & THERAPEUTICS, 2024, 26 (04) : 222 - 228
  • [9] Enhanced detection of cardiac arrhythmias utilizing 14-day continuous ECG patch monitoring
    Liu, Chih-Min
    Chang, Shih-Lin
    Yeh, Yung-Hsin
    Chung, Fa-Po
    Hu, Yu-Feng
    Chou, Chung-Chuan
    Hung, Kuo-Chun
    Chang, Po-Cheng
    Liao, Jo-Nan
    Chan, Yi-Hsin
    Lo, Li-Wei
    Wu, Lung-Sheng
    Lin, Yenn-Jiang
    Wen, Ming-Shien
    Chen, Shih-Ann
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 332 : 78 - 84
  • [10] A New-Generation Continuous Glucose Monitoring System: Improved Accuracy and Reliability Compared with a Previous-Generation System
    Christiansen, Mark
    Bailey, Timothy
    Watkins, Elaine
    Liljenquist, David
    Price, David
    Nakamura, Katherine
    Boock, Robert
    Peyser, Thomas
    DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 (10) : 881 - 888